Mitochondrial Disorders Treatment Market, Global Outlook and Forecast 2022-2028

July 2024 | 64 pages | ID: MCFD28BA9A65EN
Market Monitor Global

Abstracts

Mitochondrial disorders are inherited chronic disorders characterized by a wide range of biochemical and genetic mitochondrial defects and mutations. The disorder affects multiple organs, which includes brain, heart, liver, skeletal muscles, kidney, and respiratory systems.

This report contains market size and forecasts of Mitochondrial Disorders Treatment in Global, including the following market information:

Global Mitochondrial Disorders Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mitochondrial Disorders Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Dietary Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mitochondrial Disorders Treatment include Khondrion, Mitobridge, NeuroVive Pharmaceutical, Reata Pharmaceuticals, Stealth Biotherapeutics, Centogene, GeneDx and Ixchel Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mitochondrial Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mitochondrial Disorders Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mitochondrial Disorders Treatment Market Segment Percentages, by Type, 2021 (%)

• Dietary Therapy
• Vitamin and Supplement Therapy
• Pipeline Therapies
• Others

Global Mitochondrial Disorders Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mitochondrial Disorders Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Mitochondrial Disorders Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mitochondrial Disorders Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mitochondrial Disorders Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mitochondrial Disorders Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Khondrion
• Mitobridge
• NeuroVive Pharmaceutical
• Reata Pharmaceuticals
• Stealth Biotherapeutics
• Centogene
• GeneDx
• Ixchel Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Mitochondrial Disorders Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Mitochondrial Disorders Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MITOCHONDRIAL DISORDERS TREATMENT OVERALL MARKET SIZE

2.1 Global Mitochondrial Disorders Treatment Market Size: 2021 VS 2028
2.2 Global Mitochondrial Disorders Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Mitochondrial Disorders Treatment Players in Global Market
3.2 Top Global Mitochondrial Disorders Treatment Companies Ranked by Revenue
3.3 Global Mitochondrial Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Mitochondrial Disorders Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Mitochondrial Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mitochondrial Disorders Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Mitochondrial Disorders Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Mitochondrial Disorders Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Mitochondrial Disorders Treatment Market Size Markets, 2021 & 2028
  4.1.2 Dietary Therapy
  4.1.3 Vitamin and Supplement Therapy
  4.1.4 Pipeline Therapies
  4.1.5 Others
4.2 By Type - Global Mitochondrial Disorders Treatment Revenue & Forecasts
  4.2.1 By Type - Global Mitochondrial Disorders Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Mitochondrial Disorders Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Mitochondrial Disorders Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Mitochondrial Disorders Treatment Revenue & Forecasts
  5.2.1 By Application - Global Mitochondrial Disorders Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Mitochondrial Disorders Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Mitochondrial Disorders Treatment Market Size, 2021 & 2028
6.2 By Region - Global Mitochondrial Disorders Treatment Revenue & Forecasts
  6.2.1 By Region - Global Mitochondrial Disorders Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Mitochondrial Disorders Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Mitochondrial Disorders Treatment Revenue, 2017-2028
  6.3.2 US Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.3.3 Canada Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.3.4 Mexico Mitochondrial Disorders Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Mitochondrial Disorders Treatment Revenue, 2017-2028
  6.4.2 Germany Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.4.3 France Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.4.4 U.K. Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.4.5 Italy Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.4.6 Russia Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.4.8 Benelux Mitochondrial Disorders Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Mitochondrial Disorders Treatment Revenue, 2017-2028
  6.5.2 China Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.5.3 Japan Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.5.4 South Korea Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.5.6 India Mitochondrial Disorders Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Mitochondrial Disorders Treatment Revenue, 2017-2028
  6.6.2 Brazil Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.6.3 Argentina Mitochondrial Disorders Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Mitochondrial Disorders Treatment Revenue, 2017-2028
  6.7.2 Turkey Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.7.3 Israel Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Mitochondrial Disorders Treatment Market Size, 2017-2028
  6.7.5 UAE Mitochondrial Disorders Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Khondrion
  7.1.1 Khondrion Corporate Summary
  7.1.2 Khondrion Business Overview
  7.1.3 Khondrion Mitochondrial Disorders Treatment Major Product Offerings
  7.1.4 Khondrion Mitochondrial Disorders Treatment Revenue in Global Market (2017-2022)
  7.1.5 Khondrion Key News
7.2 Mitobridge
  7.2.1 Mitobridge Corporate Summary
  7.2.2 Mitobridge Business Overview
  7.2.3 Mitobridge Mitochondrial Disorders Treatment Major Product Offerings
  7.2.4 Mitobridge Mitochondrial Disorders Treatment Revenue in Global Market (2017-2022)
  7.2.5 Mitobridge Key News
7.3 NeuroVive Pharmaceutical
  7.3.1 NeuroVive Pharmaceutical Corporate Summary
  7.3.2 NeuroVive Pharmaceutical Business Overview
  7.3.3 NeuroVive Pharmaceutical Mitochondrial Disorders Treatment Major Product Offerings
  7.3.4 NeuroVive Pharmaceutical Mitochondrial Disorders Treatment Revenue in Global Market (2017-2022)
  7.3.5 NeuroVive Pharmaceutical Key News
7.4 Reata Pharmaceuticals
  7.4.1 Reata Pharmaceuticals Corporate Summary
  7.4.2 Reata Pharmaceuticals Business Overview
  7.4.3 Reata Pharmaceuticals Mitochondrial Disorders Treatment Major Product Offerings
  7.4.4 Reata Pharmaceuticals Mitochondrial Disorders Treatment Revenue in Global Market (2017-2022)
  7.4.5 Reata Pharmaceuticals Key News
7.5 Stealth Biotherapeutics
  7.5.1 Stealth Biotherapeutics Corporate Summary
  7.5.2 Stealth Biotherapeutics Business Overview
  7.5.3 Stealth Biotherapeutics Mitochondrial Disorders Treatment Major Product Offerings
  7.5.4 Stealth Biotherapeutics Mitochondrial Disorders Treatment Revenue in Global Market (2017-2022)
  7.5.5 Stealth Biotherapeutics Key News
7.6 Centogene
  7.6.1 Centogene Corporate Summary
  7.6.2 Centogene Business Overview
  7.6.3 Centogene Mitochondrial Disorders Treatment Major Product Offerings
  7.6.4 Centogene Mitochondrial Disorders Treatment Revenue in Global Market (2017-2022)
  7.6.5 Centogene Key News
7.7 GeneDx
  7.7.1 GeneDx Corporate Summary
  7.7.2 GeneDx Business Overview
  7.7.3 GeneDx Mitochondrial Disorders Treatment Major Product Offerings
  7.7.4 GeneDx Mitochondrial Disorders Treatment Revenue in Global Market (2017-2022)
  7.7.5 GeneDx Key News
7.8 Ixchel Pharma
  7.8.1 Ixchel Pharma Corporate Summary
  7.8.2 Ixchel Pharma Business Overview
  7.8.3 Ixchel Pharma Mitochondrial Disorders Treatment Major Product Offerings
  7.8.4 Ixchel Pharma Mitochondrial Disorders Treatment Revenue in Global Market (2017-2022)
  7.8.5 Ixchel Pharma Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Mitochondrial Disorders Treatment Market Opportunities & Trends in Global Market
Table 2. Mitochondrial Disorders Treatment Market Drivers in Global Market
Table 3. Mitochondrial Disorders Treatment Market Restraints in Global Market
Table 4. Key Players of Mitochondrial Disorders Treatment in Global Market
Table 5. Top Mitochondrial Disorders Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Mitochondrial Disorders Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Mitochondrial Disorders Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Mitochondrial Disorders Treatment Product Type
Table 9. List of Global Tier 1 Mitochondrial Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mitochondrial Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Mitochondrial Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Mitochondrial Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Mitochondrial Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Mitochondrial Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Mitochondrial Disorders Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Mitochondrial Disorders Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Khondrion Corporate Summary
Table 31. Khondrion Mitochondrial Disorders Treatment Product Offerings
Table 32. Khondrion Mitochondrial Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Mitobridge Corporate Summary
Table 34. Mitobridge Mitochondrial Disorders Treatment Product Offerings
Table 35. Mitobridge Mitochondrial Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 36. NeuroVive Pharmaceutical Corporate Summary
Table 37. NeuroVive Pharmaceutical Mitochondrial Disorders Treatment Product Offerings
Table 38. NeuroVive Pharmaceutical Mitochondrial Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Reata Pharmaceuticals Corporate Summary
Table 40. Reata Pharmaceuticals Mitochondrial Disorders Treatment Product Offerings
Table 41. Reata Pharmaceuticals Mitochondrial Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Stealth Biotherapeutics Corporate Summary
Table 43. Stealth Biotherapeutics Mitochondrial Disorders Treatment Product Offerings
Table 44. Stealth Biotherapeutics Mitochondrial Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Centogene Corporate Summary
Table 46. Centogene Mitochondrial Disorders Treatment Product Offerings
Table 47. Centogene Mitochondrial Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 48. GeneDx Corporate Summary
Table 49. GeneDx Mitochondrial Disorders Treatment Product Offerings
Table 50. GeneDx Mitochondrial Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Ixchel Pharma Corporate Summary
Table 52. Ixchel Pharma Mitochondrial Disorders Treatment Product Offerings
Table 53. Ixchel Pharma Mitochondrial Disorders Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Mitochondrial Disorders Treatment Segment by Type in 2021
Figure 2. Mitochondrial Disorders Treatment Segment by Application in 2021
Figure 3. Global Mitochondrial Disorders Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mitochondrial Disorders Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mitochondrial Disorders Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mitochondrial Disorders Treatment Revenue in 2021
Figure 8. By Type - Global Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028
Figure 12. US Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028
Figure 24. China Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Mitochondrial Disorders Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Mitochondrial Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Khondrion Mitochondrial Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mitobridge Mitochondrial Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. NeuroVive Pharmaceutical Mitochondrial Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Reata Pharmaceuticals Mitochondrial Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Stealth Biotherapeutics Mitochondrial Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Centogene Mitochondrial Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GeneDx Mitochondrial Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Ixchel Pharma Mitochondrial Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)